ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Trade (domestic/foreign) TRD

Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

Contacted: SENATE; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Federal Trade Commission (FTC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.5 Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 S.23 and H.R.1249 America Invents Act, Sections 10 and 11 (Supplemental Examination) and Section 37 (patent term extension calculation) S.27 Preserve Access to Affordable Generics Act, S.373 Fair Prescription Drug Competition Act

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Federal Trade Commission (FTC); Congressional Budget Office (CBO); White House Office; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Bills named: S. 23 (112th), S. 27 (112th), S. 373 (112th), H.R. 5 (112th), H.R. 1249 (112th)

Medicare/Medicaid MMM

FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs S.44 Medicare Prescription Drug Negotiation Act S.1356 - Affordable Medicines Utilization Act of 2011

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Bills named: S. 1356 (112th), S. 44 (112th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget

Contacted: Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Congressional Budget Office (CBO)

Pharmacy PHA

FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3026 (112th), S. 373 (112th), S. 1584 (112th), S. 44 (112th), H.R. 2245 (112th), H.R. 2182 (112th), S. 296 (112th)